Table 2.
OR | CI95% | Adjusted OR | CI95% | |
---|---|---|---|---|
Cases = 215; Controls = 265 | ||||
Maternal age | ||||
≤20 years | 1.47 | 0.73–2.95 | 0.18 | 0.05–6.36 |
21–34 years | Reference | |||
≥35 years |
1.62 |
1.02–2.58 |
4.57 |
0.94–22.06 |
Maternal age | ||||
<20 and >34 years | 1.58 | 1.05–2.37 | ||
20–34 years |
Reference |
|||
Pregestational maternal body mass index | ||||
≤18.5 kg/m2 | 1.32 | 0.44–3.91 | 2.39 | 0.20–28.36 |
18.6–24 kg/m2 | Reference | |||
25–29.9 kg/m2 | 2.16 | 1.40–3.34 | 2.37 | 0.79–7.10 |
≥30 kg/m2 |
4.81 |
2.32–10.00 |
21.0 |
1.90–232.58 |
Weight gain during pregnancy | ||||
≤9 kg | 2.34 | 1.37–4.00 | 3.14 | 0.65–15.05 |
10–11.9 kg | Reference | |||
≥12 kg |
1.40 |
0.92–2.13 |
3.67 |
1.04–12.86 |
Socioeconomic index | ||||
Low | 5.47 | 0.65–46.13 | 2.29 | 0.12–41.42 |
Middle | 4.21 | 0.49–35.64 | 3.84 | 0.19–74.85 |
High |
Reference |
|||
Working during pregnancy | ||||
Yes | 1.15 | 0.79–1.68 | ||
No |
Reference |
|||
MA ≥35, PA ≥35 | ||||
Yes | 1.35 | 1.03–1.76 | 0.45 | 0.07–2.93 |
No |
Reference |
|||
Nulliparity | ||||
Yes | 1.59 | 1.11–2.29 | 3.83 | 0.72–20.40 |
No |
Reference |
|||
Primigravida | ||||
Yes | 1.27 | 0.88–1.84 | ||
No |
Reference |
|||
Primipaternity | ||||
Yes | 1.08 | 0.75–1.56 | ||
No |
Reference |
|||
Age of menarche ≥12 years | ||||
Yes | 1.70 | 1.18–2.46 | 1.31 | 0.44–3.90 |
No |
Reference |
|||
Previous abortions | ||||
Yes | 1.45 | 0.90–2.33 | 0.88 | 0.24–3.14 |
No |
Reference |
|||
Smoking during pregnancy | ||||
Yes | 0.96 | 0.58–1.59 | ||
No |
Reference |
|||
Urinary tract infection | ||||
Yes | 1.05 | 0.71–1.55 | ||
No |
Reference |
|||
Asma | ||||
Yes | 0.92 | 0.31–2.69 | ||
No |
Reference |
|||
Allergic rhinitis | ||||
Yes | 0.73 | 0.26–2.04 | ||
No |
Reference |
|||
Anemia | ||||
Yes | 5.00 | 0.55–45.11 | ||
No |
Reference |
|||
Polycystic ovary | ||||
Yes | 2.07 | 0.49–8.80 | ||
No |
Reference |
|||
Migraine | ||||
Yes | 1.33 | 0.65–2.71 | ||
No |
Reference |
|||
Atopic dermatitis | ||||
Yes | 0.61 | 0.11–3.37 | ||
No |
Reference |
|||
History of previous preeclampsia | ||||
Yes | 6.58 | 2.89–14.97 | 30.78 | 2.65–356.73 |
No |
Reference |
|||
History of previous IUGR-SGA | ||||
Yes | 4.54 | 1.85–11.13 | 11.10 | 1.60–76.76 |
No |
Reference |
|||
Single/divorced/separated/widowed/other | ||||
Yes | 1.06 | 0.65–1.73 | ||
No |
Reference |
|||
Maternal education less than high school | ||||
Yes | 1.78 | 0.99–3.18 | 2.47 | 0.30–20.03 |
No |
Reference |
|||
Time of sexual cohabitation before conception <6 months | ||||
Yes | 1.26 | 0.68–2.35 | ||
No |
Reference |
|||
Intergenesic period ≤2 years | ||||
Yes | 1.56 | 0.89–2.73 | 2.23 | 0.67–7.40 |
No |
Reference |
|||
Family history of pre-eclampsia | ||||
Yes | 1.51 | 0.97–2.37 | 0.91 | 0.20–4.12 |
No |
Reference |
|||
Family history of IUGR-SGA | ||||
Yes | 1.09 | 0.53–2.24 | ||
No |
Reference |
|||
Family history of cardiovascular disease | ||||
Yes | 1.20 | 0.74–1.96 | ||
No |
Reference |
|||
Family history of abortions | ||||
Yes | 1.98 | 1.09–3.60 | 0.96 | 0.17–5.15 |
No |
Reference |
|||
Family history of stillbirth | ||||
Yes | 1.48 | 0.65–3.38 | ||
No |
Reference |
|||
Family history of preterm birth | ||||
Yes | 1.27 | 0.76–2.12 | ||
No |
Reference |
|||
Family history of diabetes | ||||
Yes | 1.68 | 1.12–2.52 | 3.41 | 1.09–10.67 |
No |
Reference |
|||
Family history of cancer | ||||
Yes | 0.75 | 0.47–1.20 | ||
No |
Reference |
|||
Antenatal care visits | ||||
0-3 | 2.24 | 1.13–4.41 | 0.83 | 0.12–5.37 |
4-8 | Reference | |||
>8 |
0.93 |
0.61–1.41 |
0.48 |
0.15–1.54 |
Altered uterine artery doppler | ||||
Yes | 1 | |||
No |
Reference |
|||
Paternal age | ||||
≤20 | 1.26 | 0.39–4.00 | ||
21-34 | Reference | |||
35-44 | 1.12 | 0.74–1.71 | ||
≥45 |
0.81 |
0.37–1.80 |
||
Prenatal vitamins | ||||
Yes | 0.22 | 0.06–0.78 | 0.22 | 0.06–0.79 |
No∗ | Reference |
MA: maternal age; PA: paternal age; IUGR-SGA: intrauterine growth restriction-small for gestational age.
Reference group: women who did not take any micronutrients.